HomeGOSS • NASDAQ
Gossamer Bio Inc
Follow
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 13.29M | 40.23% |
Operating expense | 54.93M | 26.57% |
Net income | -48.22M | -56.55% |
Net profit margin | -362.73 | -11.63% |
Earnings per share | -0.21 | -50.00% |
EBITDA | -41.63M | -23.53% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 180.22M | -44.89% |
Total assets | 208.82M | -40.49% |
Total liabilities | 291.15M | -1.88% |
Total equity | -82.33M | — |
Shares outstanding | 231.46M | — |
Price to book | -8.47 | — |
Return on assets | -46.29% | — |
Return on capital | -75.09% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -48.22M | -56.55% |
Cash from operations | -36.17M | -12.91% |
Cash from investing | 17.01M | 163.59% |
Cash from financing | 1.87M | 566.19% |
Net change in cash | -17.38M | 70.25% |
Free cash flow | -16.90M | -45.99% |
Previous close
$3.05
Day range
$3.02 - $3.20
Year range
$0.66 - $3.60
Market cap
703.95M USD
Avg Volume
3.02M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2015
Website
Employees
144
